Evidence map›Paper›PMID 36852616›Full record

ArticleHuman brain mapping2023

Visual impairment and retinal and brain neurodegeneration: A population-based study.

Davide Garzone, Robert P Finger, Matthias M Mauschitz, Alexandra Koch, Martin Reuter, Monique M B Breteler, N Ahmad Aziz

Open access · goldAbstract read
In one paragraph

Article in Human brain mapping, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Development and Validation of a Predictive Model for Identification of Cognitive Impairment Risk in Older Adults with Subjective Cognitive Decline:A Longitudinal Study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Davide GarzonePopulation Health Sciences, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID 0000-0001-6209-117X
Robert P FingerDepartment of Ophthalmology, Faculty of Medicine, University of Bonn, Bonn, Germany.
Matthias M MauschitzPopulation Health Sciences, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Alexandra KochPopulation Health Sciences, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Martin ReuterImage Analysis, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Monique M B BretelerPopulation Health Sciences, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
N Ahmad AzizPopulation Health Sciences, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
University of Bonn · DEGerman Center for Neurodegenerative Diseases · DEHarvard University · US

Funding

European Research Council 101041677
6 · The paper itself

Abstract

Visual impairment and retinal neurodegeneration are intrinsically connected and both have been associated with cognitive impairment and brain atrophy, but the underlying mechanisms remain unclear. To investigate whether transneuronal degeneration is implicated, we systematically assessed the relation between visual function and retinal, visual pathway, hippocampal and brain degeneration. We analyzed baseline data from 3316 eligible Rhineland Study participants with visual acuity (VA), optical coherence tomography (OCT), and magnetic resonance imaging (MRI) data available. Regional volumes, cortical volume, and fractional anisotropy (FA) were derived from T1-weighted and diffusion-weighted 3 T MRI scans. Statistical analyses were performed using multivariable linear regression and structural equation modeling. VA and ganglion cell layer (GCL) thinning were both associated with global brain atrophy (SD effect size [95% CI] -0.090 [-0.118 to -0.062] and 0.066 [0.053-0.080], respectively), and hippocampal atrophy (-0.029 [-0.055 to -0.003] and 0.114 [0.087-0.141], respectively). The effect of VA on whole brain and hippocampal volume was partly mediated by retinal neurodegeneration. Similarly, the effect of retinal neurodegeneration on brain and hippocampal atrophy was mediated through intermediate visual tracts, accounting for 5.2%-23.9% of the effect. Visual impairment and retinal neurodegeneration were robustly associated with worse brain atrophy, FA, and hippocampal atrophy, partly mediated through disintegration of intermediate visual tracts. Our findings support the use of OCT-derived retinal measures as markers of neurodegeneration, and indicate that both general and transneuronal neurodegeneration along the visual pathway, partly reflecting visual impairment, account for the association between retinal neurodegeneration and brain atrophy.

Indexed as

BrainRetinaAtrophyHumansMagnetic Resonance ImagingVision Disordersbrainmodelingneurodegenerationretinastructural equationvisual impairment

Identifiers

PMID36852616
PMCPMC10089094
OpenAlexW4322617141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.